Audio Medica News - Medical News Interviews

Audio Journal of Medicine, September 21st, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

Broad Approach, Including Computer System, to Improve Hospital Hygiene

YEHUDA CARMELI, Tel-Aviv Medical Center

REFERENCE: Abstract K-1373/ICAAC Congress 2007 Chicago 16-20 September

Hospitals can prevent significant numbers of infections by taking up a multi-faceted approach, including the use of a computer program to guide the isolation of patients. Derek Thorne spoke to Yehuda Carmeli of the Tel-Aviv Medical Center about his hospital’s experience.

Audio Journal of Medicine, September 21st, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates

PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires

REFERENCE: Abstract H-717/ICAAC Congress 2007 Chicago 16-20 September

Etravirine provides a chance to rescue patients who are failing non-nucleoside regimens according to 24-week pooled results of the DUET-1 and -2 studies. Nicola Solomon discussed these major trials with Pedro Cahn, of Juan A. Fernández Hospital in Buenos Aires.

Audio Journal of Medicine, September 21st, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

Hospital Hand Hygiene Program Successfully Rolled Out

LINDSAY GRAYSON, Austin Hospital, Victoria, Australia

REFERENCE: Abstract K-1374/ICAAC Congress 2007 Chicago 16-20 September

A hand hygiene campaign implemented in six hospitals in Victoria, Australia has saved lives from MRSA, and saved twice as much money as it cost. Lindsay Grayson from Austin Hospital explained his data to Derek Thorne.

Audio Journal of Medicine, September 21st, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns

JANE HATA, bioMéríeux Inc, Durham

REFERENCE: Slide Session C2-1360/ICAAC Congress 2007 Chicago 16-20 September

Reports from the BORIS study call for ongoing surveillance of multi-drug resistant Acinetobacter Baumanii. Investigators found varying susceptibility and resistance patterns across the United States that highlight the organisms ability to adapt. Nicola Solomon spoke with Jane Hata of bioMéríeux.

Audio Journal of Medicine, September 18th, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

Entecavir for Hepatitis B Linked to HIV Resistance

MOIRA MCMAHON, Johns Hopkins University, Baltimore

REFERENCE: Interscience Conference on Antimicrobial Agents and Chemotherapy, 17 – 20 September 2007, Chicago

The hepatitis B drug entecavir appears to select for a drug resistant HIV mutation – and this has implications for patients infected with both viruses. Derek Thorne got the details from Moira McMahon from Johns Hopkins University in Baltimore.

Audio Journal of Medicine, September 18th, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

Monoclonal Antibody to Help Treat HIV?

JEFFREY JACOBSON, Drexel University College of Medicine, Philadelphia

REFERENCE: Interscience Conference on Antimicrobial Agents and Chemotherapy, 17 – 20 September 2007, Chicago

Could a monoclonal antibody have a role to play in HIV treatment? Early data on the PRO 140 antibody, presented at ICAAC, show that it does give responses. Derek Thorne discussed this news approach with Jeffrey Jacobson of Drexel University College of Medicine, Philadelphia.

Audio Journal of Medicine, September 18th, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

Maraviroc for HIV: Responses at 48 Weeks

JACOB LALEZARI, Quest Clinical Research, San Francisco

REFERENCE: Interscience Conference on Antimicrobial Agents and Chemotherapy, 17 – 20 September 2007, Chicago

Maraviroc could be a useful new drug for the treatment of some HIV infections, according to Jacob Lalezari of Quest Clinical Research in San Francisco. He presented 48 week results from the MOTIVATE 1 study and Derek Thorne spoke to him at ICAAC in Chicago

Audio Journal of Medicine, September 18th, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

Starting Antiretroviral Therapy Can Trigger Leprosy

DIANA LOCKWOOD, London School of Hygiene and Tropical Medicine

REFERENCE: Interscience Conference on Antimicrobial Agents and Chemotherapy, 17 – 20 September 2007, Chicago

ICAAC delegates heard that ‘hidden’ leprosy can be triggered in some patients who are receiving HIV antiretroviral therapy. So what might this mean for the countries that are rolling out this therapy to large numbers of people? Derek Thorne discussed the issue with Diana Lockwood of the London School of Hygiene and Tropical Medicine.

Audio Journal of Medicine, September 18th, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses

GEORG HÄRTER, University Hospital, Ulm

REFERENCE: Interscience Conference on Antimicrobial Agents and Chemotherapy, 17 – 20 September 2007, Chicago

For patients with multiple myeloma being treated with the proteasome inhibitor bortezomib, doctor’s should be wary of viral reactivation – and they should give antiviral prophylaxis in all cases. This finding was unveiled at ICAAC by Georg Härter from the University Hospital in Ulm, and he shared his data with Derek Thorne.

Audio Journal of Medicine, September 18th, 2007

Reporting from: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

Nosocomial Clostridrium Difficile: Reduce by Cleaning with Household Bleach

DONNA HACEK, Evanston Hospital, Evanston IL

REFERENCE: Slide Session 42 K-608

Thorough, all surface bleach cleaning helps to achieve a significant and sustained reduction in nosocomial C. difficile infections according to a study from Evanston Hospital. Nicola Solomon discussed the results of this simple technique with Donna Hacek.